Clinical Pathways for Cancer Patients
Department of Veterans Affairs · VHA: Veterans Health Administration
Overview
- Development stage
- In development or acquisitionSource: a) Pre-deployment – The use case is in a development or acquisition status.
- High-impact designation
- Not high-impactSource: c) Not high-impact
- Impact justification
- Not reported
- Start date
- Not reported
- Withheld from public reporting
- Not reported
Mission
- Topic area
- Health and Medical
- Operational functions
- Document processing and extraction, Clinical and medical Derived by keyword rules; see methodology
Problem the AI is intended to solve
The VA National Oncology Program (NOP) has invested in creating clinical pathways that guide providers to provide high quality evidence-based standard of care treatments to Veterans with cancer. However, it is currently unclear how many or how often providers are ‘on pathway’ or are concordant with this recommendation. The work will focus on leveraging AI to assess the degree of adoption of various pathways. For example, the VA NOP proposes to develop, evaluate, and implement an informatics workflow that is capable of extracting information regarding whether a Veteran with prostate cancer has been offered access to germline and somatic genetic testing. This will assess care quality across the VA in terms of genetic testing in Veterans with prostate cancer and provide the necessary information to engage in quality improvement efforts. The work will follow the framework NOP developed to assess germline genetic testing in Veterans with breast cancer, in response to the Advances in Mammography and Medical Options (MAMMO) for Veterans Act of 2022. Briefly, Veterans receiving care for prostate cancer in the VA will be identified using electronic health information in the VA Corporate Data Warehouse and their latest relevant clinical notes will be retrieved.
Expected benefits
Increase efficiency: it will speed up providers' review of patients' treatment plans based on the National Oncology Program guideline, since patients' pathway information will be highlighted. This makes it easier for the providers to make better treatment decisions for the patient, therefore potentially improving patient outcomes.
System outputs
Whether a patient is on a clinical pathway and where on the clinical pathway they are
Technology
- AI classification
- Natural language processingSource: Natural Language Processing: AI that processes, interprets, and shares information in human language.
- System name(s)
- Not reported
- Custom-developed code
- Not reported
- Public source code
- Not reported
Sourcing
- How it was built
- Not reported
- Vendor (as reported)
- Not reported
- Vendors (standardized)
- None on the standard list
A vendor is the supplier named by the agency. It does not identify the underlying model or AI technology.
Data and privacy
- Involves PII
- Not reported
- Privacy Impact Assessment
- Not reported
- Authorization to Operate
- Not reported
- Demographic features
- Not reported
- Training and evaluation data
- Not reported
- Federal Data Catalog
- Not reported
Governance
0 of 8 minimum-practice questions answered. A blank answer means the agency reported nothing; it does not mean the practice is absent.
Potential impacts and how they were identified
Not reported